Paul Hastings LLP advised Semperis on the deal. Semperis, a pioneer in identity-driven cyber resilience, announced it secured $125 Million in growth financing from J. P....
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the closing of a $110...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed announced a strategic collaboration with Medtronic to develop Orchestra BioMed’s BackBeat Cardiac Neuromodulation Therapy™ (CNT™) as...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Orchestra BioMed on the deal. Loeb & Loeb LLP served as legal counsel for HSAC2. Latham & Watkins LLP represented the capital...
You must be a Standard 1 Year member to access this content.
